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The KSHV Immediate-Early Transcription Factor RTA
Encodes Ubiquitin E3 Ligase Activity that
Targets IRF7 for Proteosome-Mediated Degradation
tion. In contrast, IRF3 is often expressed constitutively
and appears to be the major player in the early phase
of IFN induction. However, in the later or amplification
phase of IFN induction, IRF7 is more critical, and its
expression becomes higher than that of IRF3. IFN,
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mRNA, whereas Sendai virus, DNA damage, and theJohns Hopkins University School of Medicine
EBV latency protein LMP1 increase IRF7 protein levels1650 Orleans Street
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activation of both IRF3 and IRF7 includes processes
that enhance phosphorylation, dimerization, and nu-
clear translocation (Au et al., 1998; Lin et al., 1998; Yo-Summary
neyama et al., 1998).
Despite the importance of IRF7 for defense mecha-Many viruses encode proteins that counteract the de-
nisms against virus infection, little is known about itsvelopment of the interferon (IFN)-mediated antiviral
physiological regulation at the protein level. IRF7 has astate. Here, we report that interferon regulatory factor
shorter half-life than IRF3 (Sato et al., 2000), and the7 (IRF7), a key mediator of type I IFN induction, is
normally low steady-state levels of IRF7 suggest thattargeted for degradation by binding to the RTA imme-
IRF7 could be regulated by the ubiquitin (Ub)-protea-diate-early nuclear transcription factor encoded by
some system. A number of other short-lived transcrip-Kaposi’s sarcoma-associated herpesvirus (KSHV or
tion factors such as P53, c-JUN, c-FOS, STAT1, c-MYC,HHV8). Cotransfection with RTA blocked IRF7-medi-
and E2F are all substrates for the Ub-proteasome path-ated IFN and IFN mRNA production and promoted
way (Kubbutat et al., 1997) in which covalent attachmentthe ubiquitination and degradation of IRF7 protein in a
of polyUb chains by the sequential action of Ub-activat-proteasome-dependent fashion. Addition of RTA also
ing enzyme (E1), Ub-conjugating enzyme (E2), and apromoted polyubiquitination of IRF7 in an in vitro cell
specific Ub ligase (E3) results in specific targeting tofree assay, demonstrating that RTA itself acts as a
the 26 S proteasome for degradation (Hershko and Cie-ubiquitin E3 ligase. RTA also autoregulated its own
chanover, 1998; Pickart, 2000).polyubiquitination and stability, and both activities
Manymechanisms for induction of IFN-mediated anti-were abolished by point mutations in a Cys plus His-
viral responses by RNA viruses have been described,richN-terminal domain. Therefore, manipulation of the
but less is known for most DNA viruses, where the pro-stability and function of IRF7 by the KSHV RTA tran-
cesses involved in both generating and overcoming anscription factor provides an unexpected regulatory
antiviral response are often complex and multifactorial.strategy for circumventing the innate immune de-
Major strategies for blocking type-1 IFN production in-fence system.
clude targeting and inhibiting the activities of either the
IRF3 or STAT transcription factors (Foy et al., 2003;Introduction
Goodbourn et al., 2000). Herpesviruses are all thought
to induce antiviral responses upon contact with the cellInterferon regulatory factors (IRFs) play critical roles in
surface, but these effects are later ablated by viral imme-modulation of the activity of the innate immune system.
diate-early lytic cycle gene products (Mossman et al.,
In particular, IRF3 and IRF7 are specific transcription
2001). For example, gene array studies in cells infected
factors that play pivotal roles in virus-induced IFN and
with both HCMV (Zhu et al., 1997) and KSHV (Poole et
IFN production that is central for the expression of al., 2002) have detected transcriptional stimulation of
IFN-stimulated genes (ISG) (Mamane et al., 1999; Marie virtually all cellular ISGs, including IRF7 mRNA, but not
et al., 1998; Sato et al., 2000; Taniguchi et al., 2001). the IFN mRNAs themselves.
IRFs can also modulate cell growth and differentiation KSHV is aDNA tumor virus of the rhadinovirus subfam-
as well as apoptosis. ily that causes rare endothelial and lymphoid tumors
Although both are essential and bind to similar ISRE- and was first discovered in Kaposi’s sarcoma (KS) in
like motifs in ISG target promoters, IRF3 and IRF7 have 1994 (Chang et al., 1994). The rates of KS disease are
distinctive roles as conditional nuclear DNAbinding pro- greatly increased by immunosuppression in both organ
teins in the induction of IFN/ genes and in establish- transplant patients and AIDS patients. The KSHV-
ment of the antiviral state. For example, the induction encoded immediate-early RTA protein studied here is a
of IFN/ promoters is nearly completely abolished in DNA binding nuclear transcription factor that can act
IRF3 and IRF7 null cells, and both are required to restore as the trigger for the entire KSHV lytic cycle (Sun et al.,
IFN responses in double knockout DKO cells (Sato et 1998). RTA targets downstream viral promoters through
al., 2000). IRF7 is a short half-lived protein that is usually both direct DNA binding and by formation of protein
expressed at very low levels, but its expression is highly complexes with at least two cellular DNA binding tran-
inducible by IFN, LPS, TPA, and RNA or DNA virus infec- scription factors, CBF1 (Liang et al., 2002) and C/EBP
(Wang et al., 2003).
In this report, we demonstrate that IRF7 is regulated*Correspondence: ghayward@jhmi.edu
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Figure 1. Detection of Physical Interactions
between the RTA and IRF7 Proteins Both In-
tracellularly and In Vitro
(A) The intact RTA(1–691) and FLAG-IRF7
(1–503) expression plasmids were cotrans-
fected at a 3 g to 10 g ratio into 293T cells.
The proteins were immunoprecipitated from
whole-cell extracts (WCE) with either anti-
IRF7 PAb, anti-RTAPab, or with a nonspecific
control antibody (IgG) as indicated then im-
munoblotted (Wb) with either the anti-IRF7
(top) or anti-RTA (bottom) antibodies. Lane 1,
10% input control.
(B) KSHV latently-infected BC2 PEL cells
were treated with TPA (20 ng/ml) for 48 hr
and MG132 (0.5 M) for the final 16 hr, then
whole-cell lysates were immunoprecipitated
with control antibody IgG (lane 2), anti-IRF7
PAb (lane 3), or anti-RTA PAb (15% input)
(lane 4) and immunoblotted with anti-RTA
PAb. Lane 1, 5% input control.
(C) RTA binds to IRF7 in vitro. [35S]-labeled
MYC-RTA(1–544) and [35S]-HA-IRF7(138–503)
were each synthesized by in vitro transcrip-
tion-translation and tested for binding by
coimmunoprecipitation with either anti-HA, anti-MYC epitope, or control IgG antibodies as indicated. Lanes 1 and 2, single input protein
controls without immunoprecipitation; lanes 3–5, mixture of both proteins incubated together before immunoprecipitation with either anti-
MYC, anti-HA, or a nonspecific Ab (IgG); lanes 6 and 7, single protein negative controls showing MYC-RTA immunopreciptated with anti-HA
MAb and HA-IRF7 immunoprecipitated with anti-MYC MAb.
(D) In vitro GST affinity binding assay. Bacterially expressed GST alone (lane 1), GST-RTA(1–691) (lane 2), or the truncation mutant GST-
RTA(1–273) (lane 3) attached to beads were incubated together with in vitro-translated [35S]-IRF7(1–503).
by the Ub-proteasome pathway and that interaction of cipitation (Figure 1B, lane 3), thus confirming that RTA
does bind to the endogenous IRF7 protein in KSHV lyti-the KSHV RTA protein with IRF7 results in a powerful
inhibitory effect on IRF7 transcriptional activation of cally infected cells.
Next, [35S]-MYC-RTA(1–544) and [35S]-HA-IRF7(138–both endogenous IFN/ mRNA synthesis and IFN/
-LUC promoter activity. The mechanism involves bind- 503) were synthesized by in vitro translation then incu-
bated together and immunoprecipitated. Both proveding to and targeting of IRF7 for degradation in a protea-
some-dependent manner and is mediated by an uncon- to be present in the immunoprecipitates obtained with
either anti-MYC or anti-HA epitope antibodies (Figureventional intrinsic Ub E3 ligase activity encoded by the
N terminus of RTA. These results imply that the Ub- 1C, lanes 3 and 4), but not in the specificity control
samples (lanes 5–7). Finally, in a GST affinity bindingproteasome pathway regulates normal IRF7 turnover
and show that its destabilization is greatly enhanced by experiment (Figure 1D), the 69 kDa in vitro translated
[35S]-labeled IRF7(1–503) protein was found to bindinteraction with RTA, which presumably contributes to
a disruption of the induced antiviral state during the strongly to purified intact GST-RTA(1–691), but not to a
truncated N-terminal GST-RTA(1–273) fragment. TheseKSHV lytic cycle.
results indicate that critical residues in RTA for IRF7
binding map between residues 273 and 544, which isResults
distinct from the N-terminal DNA binding and dimeriza-
tion domain (1–273) and from the C-terminal activationKSHV RTA Binds to IRF7 in Cotransfected Cells,
domain (544–691).in KSHV-Infected Cells, and In Vitro
During a search for human lymphocyte proteins that
bind to a truncated form of the RTA(1–544) protein with RTA Specifically Inhibits the Biological Function
of IRF7 in Inducing IFN Gene Expressionthe yeast two-hybrid system, we recovered and identi-
fied a positive clone encoding a fragment of the human To ask whether there are any functional consequences
of RTA and IRF7 interactions on type-I IFN gene expres-IRF7 protein (residues 138–503). Interaction between
the full-size, intact 69 kDa IRF7(1–503) and 110 kDa sion, we used a real-time RT-PCR quantitative IFN
mRNA assay. The wild-type (wt) IRF7(1–503) expressionRTA(1–691) proteins within mammalian cells was dem-
onstrated by coimmunoprecipitation with either anti- plasmid was introduced into 293T cells (which are
known to have very low basal levels of IRF7) to induceIRF7 or anti-RTA antibodies in cotransfected 293T cells
with IRF7 in excess (Figure 1A, lane 2). Similarly, extracts endogenous IFN and IFN mRNA synthesis. Sendai
virus was used as a potential coinducer in the experi-of BC2 PEL cells after treatment with TPA and MG132
(to induce RTA expression and reduce proteasome deg- ments shown but proved to have little added effect on
IRF7 function in these assays. Three primer pairs thatradation, respectively) gave a typical doublet of 90 plus
110 kDa RTA bands detectable after IRF7 immunopre- detect just IFN1 mRNA, a consensus for 12 IFN gene
KSHV RTA-Encoded Ub E3 Ligase Targets IRF7
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Figure 2. Inhibition of IRF7-Induced IFN
mRNA and IFN-LUC Levels by Cotrans-
fected RTA
(A) The histograms depict the levels of induc-
tion of IFN1, Pan IFN (consensus primers),
and IFN mRNA produced 48 hr after trans-
fection of 293T cells: (1) control vector DNA;
(2) wt IRF7(1–503) expression plasmid DNA
alone; or (3) and (4) IRF7 plus cotransfected
wt RTA(1–691) ormutant RTA(H145L) plasmid
DNA. All samples included Sendai virus infec-
tion for 16 hr. The relative quantitative values
of the results from SYBR Green real-time RT-
PCR assays are shown as fold increase of
IFN mRNA levels over basal levels obtained
with empty plasmid vector DNA in the ab-
sence of either IRF7 or RTA.
(B) Effect of RTA on IRF7-induced gene ex-
pression from reporter luciferase (LUC) genes
driven by the IFN and IFN promoters after
transfection into 293T cells. Target IFN1-
LUC or IFN-LUC plasmids were cotrans-
fected either with (1) vector alone; (2) IRF7
(1–503) alone; (3) IRF7 plus RTA(1–691), or (4)
IRF7 plus RTA(1–377). At 24 hr after transfec-
tion, cells were infected with Sendai virus for
12 hr before harvesting for LUC assays. The
measured LUC activity is shown as fold in-
creases over the basal level obtainedwith just
target DNA and empty vector control DNA in
the absence of either the IRF7 or RTA expres-
sion plasmids.
mRNAs (pan IFN), or IFN mRNA measured 19.5-, RTA Alters the Nuclear and Cytoplasmic
Distribution of Cotransfected IRF711.8-, and 6.5-fold induction, respectively, by IRF7 over
basalmRNA levelswith vector plasmid andSendai alone IRF7 is considered to be an intrinsically cytoplasmic
protein that needsmodification and conformational acti-(Figure 2A). However, the effect of IRF7 was nearly com-
pletely abolishedby cotransfectionwith awtRTA(1–691) vation to be translocated into the nucleus where it func-
tions as a DNA binding transcription factor (Au et al.,expression plasmid. Importantly, an RTA point mutant
with His145 changed to Leu (see later) failed to have 1998; Lin et al., 2000). In contrast, RTA is apredominantly
nuclear protein. To visualize the intracellular localizationany significant inhibitory effect.
As an alterative measure of interference with IFN tran- patterns of singly and cotransfected RTA and IRF7, we
carried out double-label IFA in 293T cells in the absencescriptional activation, we also carried out luciferase
(LUC) reporter gene assays. The basal levels of target and presence of Sendai virus to enhance the IRF7 nu-
clear activation. FLAG-tagged IRF7 alone proved to beIFN1-LUC or IFN-LUC gene activity in 293T cells were
boosted 139- and 45-fold by adding cotransfected significantly less abundant in the nucleus than in the
cytoplasm (Figures 3A–3C), although Sendai virus infec-IRF7(1–503) in the presence of Sendai virus (Figure 2B).
However, inclusion of cotransfected RTA(1–691) nearly tion increased the nuclear localization by several fold
(Figures 3D–3F). In contrast, in the cultures that werecompletely reversed the effect, with a measured inhibi-
tion of 70-fold and 26-fold, respectively. In this case, cotransfectedwith IRF7andRTA in thepresenceof Sendai
virus infection, IRF7 staining was lost completely from thean RTA(1–377) truncation mutant that both lacks the
C-terminal transactivator domain and fails to bind to nucleus in all cells as well as from the cytoplasm in about
half of those cells that were also positive for RTA (FiguresIRF7 servedas thenegative control. This result contrasts
dramatically with the strong positive transactivation ef- 3G–3I), although the nuclear distribution of RTA was unaf-
fected. The merge patterns of IRF7 and RTA expressionfect of RTA on its direct viral target promoters in similar
assays (Wang et al., 2003). in one typical coexpressing cell showing a complete
Immunity
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Figure 3. Cotransfected RTA Alters the Intracellular Localization of the IRF7 Protein
293T cells were transfected with FLAG-IRF7(1–503) alone (A–C), or infected with Sendai virus for 12 hr (D–F), or cotransfected with FLAG-
IRF7 plus RTA(1–691) and infected with Sendai virus (G–I). A higher power image of one representative selected RTA-positive cell showing
residual IRF7 in the cytoplasm but none in the nucleus is shown in (J)–(L). Single or double-label IFA with anti-FLAG MAb (red) or anti-RTA
PAb (green) was performed revealing some increased translocation of IRF7 to the nucleus in the presence of Sendai virus but the frequent
absence of IRF7 from the nucleus (and sometimes the cytoplasm as well) in cells that also expressed RTA. All cell nuclei in the fields are
shown by DAPI staining (blue in [C], [F], and [I]) and a merge of frames (J) and (K) is shown in (L).
absence of IRF7 from the nucleus, but not from the nearly completely reversed (lane 8), although MG132
had little effect in the absence of RTA (lane 10). There-cytoplasm, are also shown at high power (Figures 3J–
3L). Given that RTA interacts physically with IRF7, we fore, the ability of MG132 to restore the levels of IRF7
indicates that RTAmay indeed promote the degradationexpected to observe an increased nuclear sequestration
of IRF7 in the presence of RTA but, instead, there ap- of IRF7 via the Ub-proteasome pathway. Interestingly,
the RTA protein levels themselves also decreased at thepeared to be preferential exclusion or degradation of
presumably RTA-bound nuclear IRF7. highest input plasmid levels used (lanes 6 and 7), and
MG132 substantially increased the RTA protein levels
(lane 8), suggesting that RTA may negatively autoregu-RTA Promotes IRF7 Degradation
via the Ub-Proteasome Pathway late its own proteasome-mediated stability. Importantly,
cotransfection with mutant RTA(H145L) or truncatedTo examine whether ectopic expression of RTA could
affect the levels of IRF7 protein produced, we cotrans- RTA(1–377) failed to inhibit the accumulation of un-
tagged, intact IRF7(1–503) (Figure 4B, bottom). The RTAfected increasing amounts of the RTA plasmid together
with a constant amount of the FLAG-IRF7 plasmid. In- (H145L) point mutant also proved to be more stable than
wt RTA (top). Similar experiments to address the targetdeed, inclusion of RTA proved to decrease the level of
recovered IRF7 protein detected by immunoblotting in specificity with either STAT1 or IRF1 revealed no effects
of cotransfected RTA on their protein levels nor ofan inverse, dose-dependent manner (Figure 4A, lanes
1–7). However, in the presence of the proteasome inhibi- MG132 on Flag-IRF7 levels obtained in the absence of
RTA (Figure 4C).tor MG132, the reduction of IRF7 protein levels was
KSHV RTA-Encoded Ub E3 Ligase Targets IRF7
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Figure 4. Cotransfected RTA Reduces the Levels of IRF7 Protein in a Proteasome-Dependent Manner
(A) Dose response assay for intracellular degradation of both IRF7 and RTA. Lanes 1–7, 293T cells were cotransfected with 10 ug of FLAG-
IRF7 plus the indicated amounts of RTA plasmid DNA (1–10 ug) in the absence of Sendai virus, then WCE were prepared and immunoblotted
with anti-FLAG (top), anti-RTA (center) or anti--actin (bottom) antibodies. Lane 8, same as lane 7 except treated with MG132 at 0.6 nM for
24 hr after transfection. Lane 9, untransfected cell extract control.
(B) Inactivation of RTA-mediated inhibition of IRF7 levels by mutagenesis. The indicated wt or mutant RTA expression plasmids were cotrans-
fected into 293T cells together with wt untagged IRF7. Whole-cell lysates were then subjected to immunoblotting to detect the RTA protein
(top) or to detect the IRF7 and -actin proteins (bottom).
(C) Specificity of RTA mediated degradation: 293T cells were transfected with expression plasmids (10 g each) encoding Flag-IRF7, IRF1,
or STAT1 alone (lanes 1, 2, 5, and 7) and in the presence of cotransfected wt RTA (lanes, 3, 4, 6, and 8) or of added MG132 (lanes 2 and 4).
WCE were immunoblotted with anti-FLAG, anti-IRF1, or anti-STAT1 MAb as indicated.
Role of Phosphorylation and of a Cys/His-Rich what preferentially degraded by RTA, modification at
Ser 477 or 479 is clearly not required.Domain of RTA
To evaluate whether RTA has preferential effects on The region of RTA from positions 118–207 encompass
a cluster of six Cys and oneHis residues. To askwhetherphosphorylated IRF7, ectopic FLAG-IRF7 was ex-
pressed in 293T cells with or without cotransfected wt this domain might play a role in the degradation of IRF7,
we used site-directed mutagenesis to generate threeRTA in the presence or absence of Sendai virus and
separated into both nuclear and cytoplasmic fractions. point mutants in which either Cys or His were converted
to Ser or Leu by single nucleotide changes. In con-Immunoblotting with anti-FLAG antibody (Figure 5A) de-
tected almost exclusively the slower mobility phosphor- transfection experiments in 239T cells, mutants C131S,
C141S, and H145L as well as RTA(1-377) all proved to beylated form of IRF7 (P-IRF7) in the nucleus in both the
presence and absence of Sendai virus, whereas the inactive in decreasing both nuclear and cytoplasmic
FLAG-IRF7 protein levels (Figure 5C, top). Two of thesecytoplasmic fraction contained two closely migrating
bands of nearly equal abundance representing both point mutants also gave more abundant (and presum-
ably more stable) RTA protein levels than did wt RTA(1–phosphorylated and unphosphorylated forms of IRF7.
Added RTA proved to greatly reduce the levels of both 169), especially in the cytoplasm (Figure 5C, bottom).
nuclear and cytoplasmic IRF7, although there was clearly
some preferential degradation of phosphorylated over Detection of Polyubiquitin-Conjugated Forms
of Endogenous IRF7 and Stabilizationunphosphorylated IRF7 in the cytoplasmic fraction.
A deleted version of IRF7( 477–479), which lacks two by a Proteasome Inhibitor
To evaluate the hypothesis that turnover of IRF7 maykeySer residues and is both unable to respond to Sendai
virus induced nuclear translocation and is functionally normally be regulated by the Ub-proteasome pathway,
endogenous IRF7 levels were determined in both HeLaimpaired in IFN1-LUC reporter assays (Lin et al., 2000),
wasnevertheless still completely degraded just as effec- cells and the human B cell line DG75 before and after
treatment with MG132 (Figure 6A). As expected, only atively as the wt form by cotransfected RTA in the ab-
sence of Sendai virus (Figure 5B). Therefore, although small amount of IRF7 was detected in the absence of
the proteasome inhibitor; however, steady-state levelsthe phosphorylated forms of IRF7 appear to be some-
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Figure 5. Degradation of IRF7 Requires an N-Terminal His/Cys-Rich Domain of RTA and Occurs in Both the Nucleus and Cytoplasm and with
or without Phosphorylation
(A) Nuclear versus cytoplasmic and phosphorylated forms. 293T cells were transfected with the indicated plasmids (10 g each). Sendai virus
was added at 16 hr to one-half of the culture, and the cells were harvested at 30 hr and immunoblotted for IRF7. The nuclear and cytoplasmic
fractions shown represent 33% and 10% of the lysates, respectively. The upper phosphorylated (P-IRF) and lower unphosphorylated forms
of IRF7 are indicated.
(B) A nonphosphorylatable form of IRF7 is still susceptible to RTA degradation. To compare the effects of RTA on wt IRF7(1–503) and
phosphorylation-deficient mutant IRF7(477/479), 293T cells were transfected with the indicated target plasmids either with or without
cotransfected RTA(1–169) and WCE were immunoblotted with either anti-IRF7 PAb (top) or with anti--actin MAb (bottom).
(C) Requirement for the Cys plus His-rich N-terminal region of RTA. 293T cells were cotransfected with FLAG-IRF7 together with either empty
plasmid only, wt RTA, the three RTA point mutants, or the RTA(1–377) truncation mutant. Cell extracts were separated into nuclear (33%) and
cytoplasmic (10%) fractions and immunoblotted with either anti-FLAG (top), anti--actin (center), or anti-RTA (bottom).
of IRF7 were significantly increased in cells exposed IRF7 forms in HeLa cells, as well as by immunoprecipita-
tion of FLAG-IRF7 after cotransfection with HA-taggedto even the lowest level of MG132 tested. To directly
measure the stability of transfected wt IRF7(1–503) in Ub into 293T cells in the presence of MG132 (data not
shown).293T cells, we next carried out immunoblotting of stan-
dard whole-cell extracts (WCE) after addition of cyclo- Finally, when IRF7(1–503), IRF7(1–151), and IRF7(152–
503) were each cotransfected with pHA-Ub into 293Theximide (CHX) toblock all newprotein synthesis (Figure
6B). In the absence of MG132 (top), the levels of IRF7 cells, and the levels of in vivo ubiquitination were com-
pared after sonication in RIPA buffer, only immunopre-decreased linearly with a measured half-life of 2 hr,
whereas in the presence of MG132 (bottom), the IRF7 cipitated wt IRF7(1–503) proved to be heavily conju-
gated to polyUb, although IRF7(1–151) retained someprotein stability was increased 4- to 5-fold. This result
confirms that IRF7 is a moderately unstable protein in polyUb adducts (Figure 6D). Therefore, both N-terminal
and C-terminal segments of IRF7 are evidently requiredtransfected 293T cells and clearly implies that it is sub-
ject to proteasome-mediated negative regulation. for polyUb-conjugation.
To examine directly whether endogenous IRF7 is in-
deed subject to polyUb conjugation, DG75 cell extracts RTA Promotes the Proteasome-Mediated
Degradation of PolyUb-Conjugated IRF7were prepared by gentle sonication in RIPA buffer as
appropriate for endogenous in vivo ubiquitination assays. in Cotransfected Cells
To test whether RTA directly promotes the degradationStrikingly, high molecular weight protein smears were
detected after IRF7 immunoprecipitation by both the of IRF7 by enhancing the Ub-mediated pathway, exoge-
nous FLAG-IRF7(1–503) together with RTA(1–691) oranti-Ub and anti-IRF7 antibodies (Figure 6C). Impor-
tantly, treatment with MG132 for 16 hr at 0.5 M (lane RTA(H145L) were cotransfected together with pHA-Ub
into 293T cells for an intracellular ubiquitination assay.3), but not mock treatment (lane 2), enhanced the accu-
mulation of Ub-IRF7 conjugates. Very similar results In the absence of RTA, a slowlymigrating highmolecular
weight smear of polyUb-IRF7 was observed (Figure 7A,were obtained for immunoprecipitated endogenous Ub-
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Figure 6. Stabilization of Endogenous IRF7 Protein with the Proteasome Inhibitor MG132 and Detection of PolyUb-Conjugated IRF7 In Vivo
(A) Stabilization, HeLa and DG75 cells were exposed to TPA at 20 ng/ml to stimulate the expression of IRF7 for 24 hr and then either treated
or mock treated with MG132 at different concentrations as indicated for 6 hr. Standard whole-cell lysates were immunoblotted with anti-
IRF7 PAb.
(B) Measurement of the half-life of transfected IRF7 protein. The expression plasmid encoding wt IRF7(1–503) was transfected into 293T cells,
and cycloheximide (CHX) was added at 40 hr to block all new protein synthesis. Standard WCE were prepared at 0, 1, 2, and 4 hr either in
the presence of 0.5 M MG132/0.1% DMSO or in the presence of 0.1% DMSO solution alone as control and immunoblotted with anti-IRF7
PAb (top). The band intensities on the exposed film are plotted graphically on the bottom.
(C) Endogenous IRF7 is conjugated to polyUb in vivo. DG75 cells were either untreated (No tr, lane 1), mock treated (DMSO, lane 2), or
exposed to 0.5 M MG132/0.1% DMSO for 16 hr. WCE were prepared by sonication in RIPA buffer for in vivo ubiquitination assays, then
immunoprecipitated with anti-IRF7 antibody followed by immunoblotting with either anti-Ub MAb (top left) or with anti-IRF7 PAb (top right),
and later reprobed with anti--actin MAb (bottom).
(D) Mapping of the target region of IRF7 for endogenous polyUb-conjugation. In vivo ubiquitination assays were carried out with WCE prepared
from 293T cells by sonication in RIPA buffer after cotransfection with pHA-Ub and a control plasmid (lane 1) or each of the three indicated
wt or deleted IRF7 expression plasmids (lanes 2–4). IRF7 was immunoprecipitated from the extracts with anti-IRF7 PAb and then immunoblotted
with either anti-HA MAb (top) or with anti-IRF7 PAb (bottom).
lanes 3 and 4). However, a strikingly reduced level of dation via proteasome-mediated degradation of polyUb-
conjugated forms of IRF7 in cotransfected cells.both IRF7 conjugates and unmodified IRF7 was ob-
tained when wt RTA(1–691) was cotransfected in the
absence of MG132 (lane 5), implying that greatly en- RTA Functions as a Ub E3 Ligase for IRF7 In Vitro
in Concert with the UbcH5 E2 Enzymehanced proteasome-mediated degradation of polyUb-
IRF7 had occurred. Treatment with MG132 led to sub- To confirm that RTA itself functions directly to add
polyUb to IRF7, the E3 Ub ligase activity of RTA wasstantial rescue of both the high molecular weight IRF7
conjugates and unmodified IRF7 in the presence of RTA assessed by performing in vitro cell-free ubiquitination
assays with purified bacterial GST-IRF7 (3 g) as sub-(lane 6), but coexpression of FLAG-IRF7 with mutant
RTA(H145L) had no effect (lanes 7 and 8). These findings strate and GST-RTA added in catalytic amounts (80 ng).
Incubation together with the other standard compo-provide clear evidence that RTA promotes IRF7 degra-
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Figure 7. RTA Promotes the Ubiquitination of Both IRF7 and Itself In Vitro and the Degradation of PolyUb-IRF7 In Vivo
(A) Intracellular ubiquitination assay. 293T cells were transfected with pHA-Ub and FLAG-tagged IRF7 together with the indicated RTA
expression plasmids. Whole-cell lysates prepared by sonication in RIPA buffer were immunoprecipitated with anti-FLAG PAb and immunoblot-
ted first with anti-HA MAb to detect polyUb-conjugated forms of IRF7 (top) and then reprobed with anti-FLAG MAb to detect unmodified
IRF7 (bottom).
(B) In vitro polyUb-conjugation of IRF7 by RTA. Cell free in vitro ubiquitination reactions were carried out by incubation of the indicated purified
protein components. Input GST-RTA samples were used at catalytic levels (80 ng), whereas GST-IRF7 was used at substrate levels (3 ug).
Immunoblotting was performed to detect polyUb-conjugated and unconjugated 90 kDa GST-IRF7 by using either anti-Ub MAb (top) or anti-
IRF7 PAb (bottom).
(C) RTA exhibits self-polyUb conjugation activity. Cell free in vitro ubiquitination assays were carried out by incubation of the indicated purified
protein components. Input GST-RTA samples were used at substrate levels (3 ug). Western blotting was used to detect polyUb-conjugated
RTA with anti-Ub MAb (top) or with anti-RTA PAb (bottom).
(D) Direct detection of polyUb-conjugated RTA in vitro. Cell free in vitro ubiquitination assays with substrate level input amounts of wt GST-
RTA were carried out as in (C), except that the high molecular forms of RTA (lane 4) were detected with anti-RTA PAb on the same blot as
the unmodified form (lane 1).
nents including Ubc5H (Figure 7B) produced high mo- GST-RTA (lane 5), GST-IRF7 (lane 3), or E1 plus Ubc5H
(lane 4) all failed to yield any polyUb-conjugated bands.lecular weight Ub-containing products conjugated to
the GST-IRF7 protein as detected with anti-Ub mouse Furthermore, all three Cys/His point mutants of GST-
RTA were inactive, and substitution with either purifiedmonoclonal antibodies (MAb) (top) but did so only in the
sample containing the complete reaction components GST-SP1 protein or the deletedGST-IRF7(255–503) pro-
tein, instead of GST-IRF7(1–503) as targets, also failed(lane 9). Confirmation of the presence of the intact 90
kDa GST-IRF7(1–503) protein by Western blotting with to produce any polyUb-containing products. This result
provides unambiguous evidence that the N terminus ofanti-IRF7 antibody is shown on the bottom. Omission of
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RTA contains an intrinsic E3 Ub ligase catalytic domain understand how apparently cytoplasmic forms of IRF7
are degraded in the presence of nuclear RTA in cotrans-that functions together with the UbcH5A E2 enzyme to
specifically ubiquitinate IRF7. fected cells, wewill probably need to determine whether
binding of IRF7 to RTA is itself sufficient to translocate
IRF7 into the nucleus. In contrast, the predicted cellularRTA Also Catalyses Self-Ubiquitination In Vitro
E3 Ub ligase for IRF7 seems likely to function in theTo assess whether RTA may be capable of autoregula-
cytoplasm in the absence of Sendai virus-induced ef-tion, a similar cell-free in vitro assay was carried out
fects.with purified components, but this time by using sub-
It has been reported that removal of an apparent inhib-strate level amounts of GST-RTA (3 g) without any
itory region at the C terminus of IRF7 in IRF7(247–467)added IRF7 protein (Figure 7C). Again, E2-dependent
gives 40-fold stimulation of IFN-LUC transactivation inUb ligase activity was detected only in the reaction con-
the absence of Sendai virus (Lin et al., 2000). Therefore,taining all four bacterial-derived components, namely
this might correspond to part of the region that is tar-Ub, E1, UbcH5, and wt GST-RTA(1–169), but not in the
geted for destabilization by the cellular UbE3L. As mightabsence of either GST-RTA or UbcH5A. Substitution
be expected, we initially had considerable difficulty inwith any of the three GST-RTA Cys/His region point
demonstrating an interaction between RTA and IRF7 inmutants failed to produce a high molecular weight GST-
both BC2 PEL cells and in cotransfection experiments,RTA smear. Further confirmation that the highmolecular
but the realization that targeting of IRF7 by RTA led toweight HA-polyUb containing bands observed in vitro
its degradation allowed us to adjust the conditions bydo indeed represent polyUb-conjugated forms of RTA
using the proteasome inhibitor in BC2 cells and highitself was obtained by immunoblotting with anti-RTA
input ratios of IRF7 to RTA in the cotransfection experi-antibody (Figure 7D). The resulting high molecular weight
ments.forms of RTA were only generated after incubation in
the presence of E1, E2, and Ub, but not in their absence
nor in the absence of GST-RTA. These results affirm Role of the Cys Plus His-Rich Region of RTA
that RTA is indeed able to catalyze self-ubiquitination in the Degradation of IRF7 and Self-Ubiquitination
in vitro and that this self-catalyzed activity requires the Our results indicate that KSHV RTA specifically targets
same Cys plus His-rich region involved in polyUb conju- the IRF7 protein for proteasome degradation, whether
gation to IRF7. in the nucleus or cytoplasm, thus greatly reducing the
steady-state levels of activated IRF7 protein and abol-
Discussion ishing transcriptional stimulation of IFN and IFN
mRNAs. The ability of RTA to target both IRF7 and itself
Normal Control of IRF7 Protein Levels for polyUb conjugation and subsequent proteasome-
via the Ub-Proteasome Pathway mediated degradation strongly implies that RTA, like
Our evidence here clearly indicates that the levels of the cellular HPV E6-associated E6-AP (Scheffner et al.,
accumulation of the relatively short half-lived IRF7 pro- 1993), the HSV-encoded ICP0 (Boutell et al., 2002; Hag-
tein are tightly regulated by the Ub-proteasomepathway glund et al., 2002), and the KSHV-encoded MIR1 (K3)
in normal human cells, presumably under the control andMIR2 (K5) proteins (Coscoy andGanem, 2003), pos-
of a specific cellular Ub E3 ligase. Although polyUb- sesses an intrinsic E3 ligase activity. Autoubiquitination
conjugation of IRF1 (Nakagawa and Yokosawa, 2000) is a common feature of some E3 ligases and is therefore
and sensitivity of IRF3 to proteasome inhibitors (Lin et a good indicator of intrinsic E3 activity. Three key resi-
al., 1998) have been described, the mechanism for con- dues, Cys131, Cys141, and His145, were identified that are
trolling the endogenous activity and turnover of IRF7 each absolutely required for promoting the degradation
has not previously been addressed. Evidently, KSHV of IRF7 as well as for RTA self-ubiquitination. Impor-
exploits this pathway to block IRF7 function and the tantly, all three of the RTA catalytic region point mutants
KSHVRTA transcription factor has also evolved an enzy- still retain their ability to bind to both the IRF7 and
matic domain that has functional parallels with the pre- C/EBP proteins and to bind to target RRE DNA motifs
dicted cellular Ub E3 ligase for IRF7. in EMSA experiments (data not shown). They also retain
about 70% of their normal level of transactivation of
viral target promoters, suggesting that these mutantsMechanism of RTA-Mediated Regulation
of IRF7 Protein Stability specifically abrogate only the E3 ligase function of RTA.
Although the proposed intrinsic RTA E3 ligase catalyticAlthough phosphorylation may contribute to enhance-
ment of the RTA-mediated Ub-dependent degradation activity encompasses a novel Cys-rich region from
amino acids 118–207 (Cys3HisCys3), sequence compar-of IRF7 in vivo, the preference is clearly not an absolute
requirement because firstly, at the highest ratios of RTA isons show no significant similarity between this domain
and any previously described conserved E3 ligase do-to IRF7 used in many of our cotransfection experiments,
all IRF7 protein present in the both the nucleus and mains.
There are two distinct types of E3 ligase known: thecytoplasm was degraded (e.g., see Figures 4B, 5B, and
5C). Secondly, deletion of the two key phosphorylated enzymatic HECT domain E3s and the zinc finger domain
E3s, including two classes of RING-finger related do-Ser residues at position 477 and 479 in IRF7 did not
prevent RTA-mediated degradation (Figure 5C) Thirdly, mains, the U box and PHD domain E3s. The recognition
that RING finger proteins can bind E2 enzymes in aefficient IRF7 ubiquitination of presumably unphosphor-
ylated GST-IRF7 was observed in vitro (Figure 7B). To specific and catalytically productive manner represented
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a major advance in Ub biochemistry (Pickart, 2000). A duction in KSHV-infected endothelial cell cultures de-
spite the strong induction of the mRNAs for IRF7 andnumber of RING or PHD domain containing viral Ub E3
ligases have been identified, including HSV-encoded many other ISGs (Poole et al., 2002). Nevertheless, KSHV
infection itself probably has additional redundant levelsICP0 (the prototype classic RING-finger protein) and
a subclass of KSHV-encoded membrane-bound PHD of response to cellular antiviral effects. For example,
two other KSHV-encoded early lytic cycle proteins haveproteins (vMIR1 and vMIR2) that target MHC class I
degradation (Coscoy and Ganem, 2003; Ishido et al., been implicated as negative regulators of IRF re-
sponses. vIRF1 inhibits IRF1 by competing for binding2000). Unlike the HSV ICP0 immediate-early nuclear pro-
tein, which has E3 ligase activity but for which only to p300 (Gao et al., 1997; Li et al., 2000; Zimring et al.,
1998), and ORF45 specifically binds to IRF7 and maysubstrate-independent formation of polyUb has been
demonstrated so far in vitro (Boutell et al., 2002; Hag- sequester it in the cytoplasm (Zhu et al., 2002). Our
functional transfection assays for inhibition of IFNmRNAglund et al., 2002), we have obtained clear evidence
here for specific Ub-conjugation of the target IRF7 pro- synthesis by RTA gave at least 10-fold stronger effects
than were reported by any of these other studies, buttein in vitro by the RTA Ub E3 ligase activity.
A variant, noncanonical Cys plus His rich domain as- whether RTA-mediated processes are truly more domi-
nant in KSHV-infected endothelial and B lymphocyctesociated with E3 activity was described recently in the
Mumps virus V protein that degrades STAT1 in a ubiqui- cells remains a subject for future evaluation.
tin-dependent manner (Yokosawa et al., 2002). There-
fore, functional E3 protein domains may not be limited Experimental Procedures
just to the currently known motifs, and KSHV RTA may
represent another variant of Cys plus His-rich E3 ligases. Plasmids and Expression Vectors
Expression plasmids encoding IRF7A(1–503), FLAG-IRF7A(1–503),
GST-IRF7(1–503), and GST-IRF7(255–503) and reporter plasmidsTargeting Specificity of RTA Ub E3 Ligase Activity
encoding firefly luciferase (LUC) under the control of human IFN1A central domain of RTA between amino acids 273–544 (140/9) and IFN (280/20) promoter elements were provided
binds to IRF7 and presumably brings it into proximity by Yan Yuan (Zhu et al., 2002). Similar CMV-enhancer driven expres-
with the adjacent RTA catalytic region. When most of sion plasmids (pYXY7 and pYXY8) encoding IRF7(1–151) or IRF7(152–
503) were generated by deletion from the parent intact IRF7(1–503)this segment was deleted in RTA(1–377), both the tar-
version. Mammalian expression plasmids pJX15 and pSEW-R01geted ubiquitination and degradation of IRF7 were abol-
encode full length cDNA versions of RTA(1–691) driven by the SV40ished, despite the continued presence of the N-terminal
or HCMV enhancer-promoter regions. The RTA(1–377) C-terminalcatalytic domain. This organization resembles that in truncation mutant in plasmid pSEW-R03, GST fusion versions of
E6-AP which is well known to target p53 for degradation full-lengthGST-RTA(1–691), GST-RTA(1–544), GST-RTA(1–377), and
by the Ub-proteasome pathway in association with HPV GST-RTA(1–273) were all described elsewhere (Wang et al., 2003).
TheGAL4-RTA(1–544) DNAbinding domain fusion protein in plasmidE6 (Scheffner et al., 1993).
pYXY1 was generated in the yeast vector pAS2-1 (Clontech) by PCRTo begin to evaluate whether RTAmay have a broader
amplification from KSHV RTA cDNA.target specificity than just IRF7, we have also carried out
preliminary experiments to test whether cotransfection
with RTA negatively affects the accumulation of other Site-Directed Mutagenesis
Several point mutants in RTA(1–691) plasmid pSEW-R01 were cre-IRFs and transcription factors. The results showed that
ated with the Quik-Change site-directed mutagenesis kit (Stra-cotransfection with RTA also leads to degradation of
tagene). The oligonucleotide primers used were as follows: C131SIRF3 (data not shown) but has noeffect on IRF1 orSTAT1
sense, 5-GCATTTCTGACAGCCGCAAGCAGCGGGGTGAGCCTG
protein levels. In contrast, as described previously, the CCT-3; C131S antisense, 5-AGGCAGGCTCACCCCGCTGCTTGCG
C/EBP level was significantly elevated by coexpressed GCTGTCAGAAATGC-3; C141S sense, 5-AGCCTGCCTCCAGCCAT
ATCTAAGCTACTACACGAAATA-3; C141S antisense, 5-TATTTCGTRTA (Wang et al., 2003).
GTAGTAGCTTAGATATGGCTGGAGGCAGGCT-3; H145L sense, 5-The discovery that RTA itself has an unconventional
GCCATATGTAAGCTACTACTCGAAATATACACTGAGATG-3; H145Lintrinsic Ub E3 ligase activity is even more remarkable
antisense, 5-CATTTCGGTGATTATTTCGAGTAGTAGCTTACATATconsidering that one of the other RTA binding cellular
GGC-3. These were used to create plasmids pYXY4, pYXY5, and
proteins recovered from the yeast two-hybrid library pYXY6 encoding RTA(1–691/C131S), RTA(1–691/C141S), and RTA(1–
screen was a HECT domain Ub E3 ligase protein. We 691/H145L), respectively. The same mutations were also all moved
into the GST-RTA(1–691) background to create plasmids (pYXY 9,have found that this cellular protein not only binds to
10, and 11).both RTA and IRF7 but also catalyses polyUb-conjuga-
tion and proteasome-dependent degradation of IRF7
and IRF3 (Y.Y. and G.S.H., unpublished data). This may Antibodies
well be the predicted cellular Ub E3 ligase for IRF7. MAb against -actin, FLAG (M2), HA, and MYC-epitopes were pur-
chased from Sigma. Rabbit polyclonal antibody (PAb) against GST-Therefore, RTA may both act as an E3 ligase itself to
IRF7(1-390), FLAG-epitope, and ubiquitin were purchased fromSan-specifically target IRF7 for destruction via the Ub-pro-
taCruz (SC9053) or Sigma. Rabbit anti-peptide PAb recognizing RTAteasome pathway, as well as recruit and modulate a
residues 527–539 was described previously (Wang et al., 2003).
cellular E3 ligase that regulates IRF-related pathways.
Yeast Two-Hybrid ScreeningPossible Role in KSHV-Infected Cells
The KSHV RTA bait plasmid (pYXY1) was cotransfected into AH109All of our data here argue that RTA by itself can specifi-
yeast cells with a human EBV-infected lymphocyte cDNA library
cally and very efficiently target IRF7 for degradation (Clontech, Matchmaker). Yeast colonies containing interacting pro-
both in the nucleus and less efficiently in the cytoplasm, teins were identified by growth on media lacking Ade, His, Leu, and
Trp and confirmed by assaying for -galactosidase activity.which could account for the absence of IFN mRNA in-
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Cell Cultures, Transient Transfection, Indirect IFA, Nuclear, pan) for the pHA-Ub plasmid; and John Hiscott (McGill University,
Montreal, Canada) for IRF7(497/499).We also thankCecileM. Pick-and Cytoplasmic Extracts and Immunoblotting
293T cells and HeLa cells were cultured in DMEM. The BC2 lympho- art and Min Wang (Bloomberg School of Hygiene, Johns Hopkins
University) for critically reading the manuscript and for technicalblastoid PEL cell line and the DG75 lymphoblast cell line (EBV and
KSHV negative) were all maintained in RPMI medium. The KSHV advice.
lytic cycle in BC2 cells was induced by treatment with TPA (20
ng/ml) for 40 hr. Transient cotransfection assays by lipofection, IFA, Received: December 2, 2003
separation of nuclear, and cytoplasmic fractions by NP40 lysis, and Revised: October 14, 2004
immunoblotting procedures were all performed as described else- Accepted: November 17, 2004
where (Wang et al., 2003; Wu et al., 2003). In all experiments de- Published: January 25, 2005
picting nuclear versus cytoplasmic fractionation, the relative ratios
of input sample used were 3.3 to 1.
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